FDA Approves Nemluvio for Prurigo Nodularis
THURSDAY, Aug. 15, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31...